Countdown to Next Report: Special Report with Game-Changing Potential Coming Your Way

Ratings changes for Enphase Energy, SolarEdge Technologies, Esperion Therapeutics, Micron Technology, Ocular Therapeutix, Iovance Biotherapeutics, United Therapeutics and more...Text "MarketBeat" to 68285 to get SMS breaking news alerts for stocks on your watchlist and other special reports. Learn More. Unsubscribe. VIEW MY PORTFOLIO June 20th, 2024     Nvidia's Quiet $1 Trillion Pivot (ad) Nvidia recently added $277 billion in market cap … IN ONE DAY. Find out details on these three critical Nvidia partners immediately. Today's Top Stories Celsius Stock: Why Piper Sandler Forecasts a 50% Surge 580,000 glass coffee mugs recalled because they can break when filled with hot liquid AI "wealth window" will close June 25 (Paradigm Press) Accenture's Stock Earnings Reveal an AI-Powered Growth Strategy Mike Pence's foundation launches a $10 million election-year campaign to preserve Trump-era tax cuts 3 Tech Stocks Insiders, Major Shareholders, and Institutions Buy The Supreme Court upholds a tax on foreign income over a challenge backed by business interests Nvidia's missing link? (Porter & Company) Top 3 Stocks to Buy Now as Energy Sector Hits Buy Zone NATO member Romania to send a Patriot missile system to neighboring Ukraine Autodesk Stock Up 25%, Analysts Want More Double-Digit Gains China protests over EU move to hike tariffs on Chinese electric vehicles Quick Links MarketBeat All Access My MarketBeat Account Settings Mobile App Analyst Ratings Buy this small stock before coming AI Tidal Wave (ad) The internet generated more wealth than any other innovation in history - creating hundreds of thousands of new millionaires in America alone. Now A.I. could do the same. But if you're buying Microsoft or NVIDIA to profit - you're missing the big picture. Get the name and ticker symbol for free - just click here. Your Watchlist (Manage Your Watchlist and Monitor Your Portfolio)   Blackbaud, Inc. (BLKB) No Headlines, Ratings, Earnings Results, Dividends, Insider Trades, Options Activity, Company Press Releases or Headlines Today   CCC Intelligent Solutions Holdings Inc. (CCCS) (6/19) Quadrature Capital Ltd Boosts Stake in CCC Intelligent Solutions Holdings Inc. (NYSE:CCCS) (marketbeat.com)   Lumen Technologies, Inc. (LUMN) No Headlines, Ratings, Earnings Results, Dividends, Insider Trades, Options Activity, Company Press Releases or Headlines Today   Transcontinental Realty Investors, Inc. (TCI) No Headlines, Ratings, Earnings Results, Dividends, Insider Trades, Options Activity, Company Press Releases or Headlines Today   WillScot Mobile Mini Holdings Corp. (WSC) No Headlines, Ratings, Earnings Results, Dividends, Insider Trades, Options Activity, Company Press Releases or Headlines Today Analysts' Upgrades ASM International (OTCMKTS:ASMIY) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating.The current price is $757.65. Bread Financial (NYSE:BFH) was upgraded by analysts at Evercore ISI from an "underperform" rating to an "in-line" rating. They now have a $45.00 price target on the stock, up previously from $42.00. This represents a 4.4% upside from the current price of $43.11. DLocal (NASDAQ:DLO) was upgraded by analysts at UBS Group AG from a "sell" rating to a "neutral" rating. They now have a $9.00 price target on the stock, down previously from $13.00. This represents a 20.3% upside from the current price of $7.48. First Quantum Minerals (OTCMKTS:FQVLF) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating.The current price is $12.12. HomeStreet (NASDAQ:HMST) was upgraded by analysts at Janney Montgomery Scott from a "neutral" rating to a "buy" rating. They now have a $13.50 price target on the stock. This represents a 22.5% upside from the current price of $11.02. iRhythm Technologies (NASDAQ:IRTC) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating. They now have a $115.00 price target on the stock. This represents a 10.1% upside from the current price of $104.46. Ocular Therapeutix (NASDAQ:OCUL) was upgraded by analysts at TD Cowen from a "hold" rating to a "buy" rating. They now have a $11.00 price target on the stock, up previously from $7.00. This represents a 82.7% upside from the current price of $6.02. Skyworks Solutions (NASDAQ:SWKS) was upgraded by analysts at B. Riley from a "neutral" rating to a "buy" rating. They now have a $130.00 price target on the stock, up previously from $96.00. This represents a 21.6% upside from the current price of $106.95. TransUnion (NYSE:TRU) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating. They now have a $92.00 price target on the stock. This represents a 24.3% upside from the current price of $74.00. Williams Companies (NYSE:WMB) was upgraded by analysts at Argus from a "hold" rating to a "buy" rating.The current price is $42.35. View today's most recent analysts' upgrades at MarketBeat.com Historic NVIDIA partnership could send this tiny AI stock soaring... (ad) After striking partnerships with trillion-dollar chipmaker NVIDIA... ARM surged over 60% in a week... Who's next? Click here to discover the name and ticker symbol >>> Analysts' Downgrades British Land (OTCMKTS:BTLCY) was downgraded by analysts at Stifel Nicolaus from a "buy" rating to a "hold" rating.The current price is $5.41. Deutsche Lufthansa (OTCMKTS:DLAKY) was downgraded by analysts at Stifel Nicolaus from a "buy" rating to a "hold" rating.The current price is $6.47. Esperion Therapeutics (NASDAQ:ESPR) was downgraded by analysts at Bank of America Co. from a "neutral" rating to an "underperform" rating. They now have a $2.50 price target on the stock, down previously from $2.90. This represents a 7.3% upside from the current price of $2.33. Prelude Therapeutics (NASDAQ:PRLD) was downgraded by analysts at Barclays PLC from an "equal weight" rating to an "underweight" rating. They now have a $3.00 price target on the stock. This represents a 20.0% downside from the current price of $3.75. Ryanair (NASDAQ:RYAAY) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating.The current price is $115.06. Wärtsilä Oyj Abp (OTCMKTS:WRTBY) was downgraded by analysts at Deutsche Bank Aktiengesellschaft from a "buy" rating to a "hold" rating.The current price is $4.44. Zentalis Pharmaceuticals (NASDAQ:ZNTL) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating. They now have a $5.00 price target on the stock, down previously from $28.00. This represents a 6.9% downside from the current price of $5.37. View today's most recent analysts' downgrades at MarketBeat.com AI's Next Magnificent Seven (ad) The Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years. See His Breakdown of the Seven Stocks You Should Own Here. Analysts' New Coverage Birkenstock (NYSE:BIRK) is now covered by analysts at BNP Paribas. They set an "outperform" rating and a $68.00 price target on the stock. This represents a 11.5% upside from the current price of $60.99. ESAB (NYSE:ESAB) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $115.00 price target on the stock. This represents a 19.4% upside from the current price of $96.29. Samsara (NYSE:IOT) is now covered by analysts at Bank of America Co.. They set a "buy" rating and a $37.00 price target on the stock. This represents a 25.2% upside from the current price of $29.55. Vericel (NASDAQ:VCEL) is now covered by analysts at TD Cowen. They set a "buy" rating and a $55.00 price target on the stock. This represents a 22.7% upside from the current price of $44.81. Virios Therapeutics (NASDAQ:VIRI) is now covered by analysts at Maxim Group. They set a "buy" rating and a $1.00 price target on the stock. This represents a 308.5% upside from the current price of $0.24. Vodafone Group Public (NASDAQ:VOD) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "buy" rating on the stock.The current price is $9.10. View today's most recent analysts' new coverage at MarketBeat.com Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. START YOUR 30-DAY FREE TRIAL Calendars from MarketBeat U.S. Analyst Ratings Corporate Buybacks Cryptocurrencies Dividend Declarations Earnings Announcements Economic Reports Gap Up/Down Stocks Insider Trades Initial Public Offerings (IPOs) Most Active Stocks Percentage Gainers/Decliners Sector Performance Short Interest Unusual Options Volume Unusual Trading Volume Upgrade Your Subscription Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET. UPGRADE NOW Manage Your Watchlist View and add up to five holdings to your watchlist. VIEW MY PORTFOLIO Join Our Facebook Group Join MarketBeat's free stock discussion and trading idea group on Facebook. JOIN NOW

Thank you for subscribing to MarketBeat! We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.   If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails.   © 2006-2024 MarketBeat Media, LLC. 345 N Reid Place, Suite 620, Sioux Falls, SD 57103. United States.   Today's Bonus Content: The #1 Crypto That You Don't Own… Yet